Zennie Abraham / Zennie62
tech

Ophthotech may get over $1 billion from eye drug deal with Novartis – Chicago Tribune (blog)

Ophthotech may get over $1 billion from eye drug deal with Novartis
Chicago Tribune (blog)
Ophthotech is testing Fovista in late-stage studies to treat wet age-related macular degeneration (AMD), in combination with standard treatments including Regeneron Pharmaceuticals Inc’s Eylea and Roche Holding AG’s Avastin and Lucentis. Ophthotech …

…read more

Source: Wet Macular Degeneration News From Google News

Zennie Abraham
Zennie Abraham | Zennie Abraham or "Zennie62" is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.
https://www.zennie62blog.com

Leave a Reply

Your email address will not be published.